CDKN2A and breast carcinoma: Hui et al [29] demonstrated an inverse relationship between p16INK4a and ER mRNA levels in cell lines and primary breast cancers, suggesting that p16INK4a inactivation by hypermethylation and overexpression is a marker of poor prognosis.